![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 11, 2020 4:43:43 PM
Item 8.01 Other Events.
As previously announced, on December 30, 2019 Seamus Lagan, Chief Executive Officer and President of Rennova Health, Inc. (the “Company”), and Alcimede LLC, of which Mr. Lagan is the sole manager, approved by written consent in lieu of a special meeting of stockholders two proposals that had previously been approved by the Board of Directors of the Company. Mr. Lagan and Alcimede LLC held shares representing 50.9% of the total voting power of the Company’s voting securities with regard to these proposals. The proposals were (i) to approve an amendment to our Certificate of Incorporation to increase the authorized shares of our common stock from 10,000,000,000 to 12,500,000,000 shares, and (ii) to approve an amendment to our Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock at a specific ratio from 1-for-100 to 1-for-10,000, reduce the number of authorized shares of common stock to 3,000,000,000 shares and grant authorization to our Board of Directors to determine, in its discretion, the specific ratio and timing of the reverse split any time before December 31, 2020, subject to the Board of Directors’ discretion to abandon such amendment.
Our Board of Directors has determined not to proceed with these two proposals but currently expects to move forward with a reverse stock split of our common stock on its own, without any change in the authorized shares of our common stock at this time. If and when the Board does determine to authorize a reverse split, it will adopt a resolution to that effect and seek a new stockholder approval.
Recent RNVA News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:46:02 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 08:15:33 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 08:40:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 08:30:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 12:52:37 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM